Stockhead on MSN20h
Dimerix banks initial $3.2m payment in Japanese pharma licensing deal for kidney drug
Special Report: Dimerix has received the initial payment of ¥300 million (A$3.2 million) in line with its recently announced ...
ASX February health winners: Sector falls almost 8pc in weaker month for markets
Index fell 7.66% in February to be the second-worst performing sector for the month as the local bourse felt the pressure of ...